The role of metabolic tumor volume and total lesion glycolysis on 18F-FDG PET/CT in the prognosis of epithelial ovarian cancer
- 23 May 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 41 (10), 1898-1906
- https://doi.org/10.1007/s00259-014-2803-x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Prognostic Value of Metabolic Tumor Burden from 18F-FDG PET in Surgical Patients with Non–small-cell Lung CancerAcademic Radiology, 2012
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological featuresVirchows Archiv, 2012
- Prognostic Value of Volume-Based18F-Fluorodeoxyglucose PET/CT Parameters in Patients with Clinically Node-Negative Oral Tongue Squamous Cell CarcinomaKorean Journal of Radiology, 2012
- Nodal status—its impact on prognosis in advanced ovarian cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2011
- FDG-PET/CT for diagnosis of primary ovarian cancerNuclear Medicine Communications, 2011
- Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2011
- Phantom Study on Radiotherapy Planning Using PET/CTJournal of Radiation Research, 2010
- Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histologyNuclear Medicine Communications, 2007
- Carcinoma of the OvaryInternational Journal of Gynecology & Obstetrics, 2006
- Survival and prognostic factors in patients with ovarian cancerObstetrics & Gynecology, 2003